Allscripts (MDRX) Tops Q1 EPS by 4c; Provides FY21 Revenues Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
JPMorgan Resumes Allscripts (MDRX) at Underweight
April 29, 2021 6:17 AM EDTJPMorgan analyst Anne Samuel resumes coverage on Allscripts (NASDAQ: MDRX) with a Underweight rating and a price target of $15.00.
For an analyst ratings summary and ratings history on Allscripts click here. For more ratings news on Allscripts click here.
Shares of Allscripts closed at $15.83 yesterday.
... More
